Hunter syndrome Info

Helping to raise awareness of MPS II, from prompt clinical suspicion and referral to testing for an earlier diagnosis.

Many of the signs and symptoms of Hunter syndrome are common childhood complaints; being able to recognise these in combination may reduce the diagnostic delay.

Improving the quality of life of MPS II patients and their families with an early diagnosis and appropriate management.

This podcast highlights the risks associated with surgery in patients with mucopolysaccharidosis type II (MPS II) and explains the need for multidisciplinary management to minimise these risks.

This podcast highlights the clinical manifestations of Mucopolysaccharidosis type II (MPSII) and examines the multidisciplinary approach to managing these for optimal patient care.

This podcast, aimed at doctors and other health care professionals, summarises the importance of understanding family histories to help in decreasing the time it takes to diagnose mucopolysaccharidosis type II (MPS II).

In this episode, our panel discusses how advancements in technology, along with an improved understanding of MPS II, have moved diagnostic testing a long way since MPS II (Hunter syndrome) was first characterised by Charles Hunter more than 100 years ago. Learn about the history of diagnosis of MPS II, and current diagnostic challenges, featuring interviews with Professor Anna Tylki-Szymanska (The Children’s Memorial Health Institute, Warsaw), Professor Maurizio Scarpa (Udine University Hospital, Italy), Dr. David Whiteman (Takeda Pharmaceutical Company Limited), and Robert Hollowell (Takeda Pharmaceutical Company Limited).

MPS II (Hunter syndrome) is one of 7 mucopolysaccharidoses (MPS) diseases: a group of rare, genetic, metabolic disorders.

This podcast series was initiated, organised, and funded by Takeda Pharmaceutical Company Limited, and is intended for international healthcare professional audience outside of the USA and the UK.

C-ANPROM/INT//5607 June 2019

ENTs are among the most likely physicians to recognise the early signs and symptoms of Hunter syndrome. Expert ENT Dr Umut Akyol discusses the ENT symptoms that could lead to suspicion of Hunter syndrome, and Professor Roberto Giugliani, a leading geneticist who has been working in the field of metabolic disease for 40 years, outlines the importance of the multidisciplinary team in caring for people with Hunter syndrome.

This podcast series was initiated and funded by Shire and is intended for a global healthcare professional audience.

C-ANPROM/INT//2693

Professor Joseph Muenzer, Hartmann Wellhoefer MD and Professor Chris Hendriksz discuss the challenges facing rare disease diagnosis and the diagnostic odyssey that rare disease patients often undertake.

Professor Joseph Muenzer outlines the biochemistry of the MPS disorders and provides key insights on the signs and symptoms of Hunter syndrome. Learn more about MPS diseases and Hunter syndrome, and how you can improve the identification and management of these rare, progressive disorders.

This podcast series was initiated and funded by Shire and is intended for an international healthcare professional audience.

C-ANPROM/INT//2351